advantageaustria.org does not support this browser, some features and elements are not supported. Please use another browser such as Firefox, Chrome, Edge etc.
APEPTICO develops therapeutic peptide drugs for the treatment of life-threatening and chronic illnesses using the discovery platform PEPBASE™ and PEPSCREEN™.
AP301 brings about fluid reabsorption in lung oedema and protects endo- and epithelia from hyperpermeability caused by inflammation of the lung. Furthermore, ...